Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1998
06/02/1998US5760015 Cyclodextrin compounds and methods of making and use thereof
06/02/1998US5760014 Administering a blend of dextrose, dextrin, maltodextrin or mixtures with starches
06/02/1998US5760012 Genetic engineered nucleotide for treating genetic disorders
06/02/1998US5760011 Antibiotic macrolides
06/02/1998US5760010 Method of treating liver disorders with a macrolide antibiotic
06/02/1998US5760009 Anticholesterol agents
06/02/1998US5760008 Method and compositions for treating malignant tumors and inhibiting metastases of malignant tumors
06/02/1998US5760007 Anticonvulsant derivatives useful in treating neuropathic pain
06/02/1998US5760006 Anticonvulsant derivatives useful in treating psoriasis
06/02/1998US5759993 Modified sialyl Lewisx compounds
06/02/1998US5759837 Antitumor agents and anticarcinogenic agents
06/02/1998US5759791 Kits for diagnosis of breast cancer using antibodies
06/02/1998US5759610 Trehalose and its production and use
06/02/1998US5759586 Mixture of sodium, potassium, magnesium and calcium (bi)carbonates and enzyme activators
06/02/1998US5759585 Plasmalogen compositions and their use in neurodegenerative diseases treatment
06/02/1998US5759584 Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester
06/02/1998US5759583 Polylactic/glycolic acid copolymer, bioactive agent and quaternary ammonium surfactant
06/02/1998US5759580 Hypotensive agents
06/02/1998US5759577 Controlled release of steroids from sugar coatings
06/02/1998US5759576 Controlled release of steroids from sugar coatings
06/02/1998US5759567 Administering to poultry l-dihydroxyphenylalanine to reduce the ratio of saturated to unsaturated fatty acids in eggs
06/02/1998US5759544 Antibody-containing oral composition for suppression of periodontal disease
06/02/1998US5759532 Controlled release of miotic and myriatic drugs in the anterior chamber
06/02/1998US5759528 Topical composition for promoting transdermal absorption of therapeutic agents
06/02/1998US5759525 Concentrated solutions of a 1,3,5-triazine derivative sunscreen and their use for the preparation of cosmetic compositions
06/02/1998CA2158632C Catechol diether compounds as inhibitors of tnf release
06/02/1998CA2019013C Process to improve the therapeutic efficacy of fat-soluble corticosteroids and composition for the application of this process
06/02/1998CA2006896C Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
06/02/1998CA1339896C Dideoxydidehydrocarbocyclic nucleosides
06/02/1998CA1339895C Piperidinoalkyl derivatives of carboxylic acid amides
05/1998
05/29/1998CA2219849A1 Composition for cosmetic, pharmaceutical or dietetic use based on an amino sugar and/or a polyhydroxylic acid
05/28/1998WO1998022619A1 Metal mediated serine protease inhibitors
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022506A1 Human kdel receptor
05/28/1998WO1998022494A2 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS
05/28/1998WO1998022492A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998WO1998022483A1 New phosphonates, process for preparing the same and medicaments
05/28/1998WO1998022479A1 Pharmaceutical formulations
05/28/1998WO1998022471A1 Ethylenediaminetriacetic acid and n-acyl ethylenediaminetriacetic acid silver chelactants
05/28/1998WO1998022467A1 New process for the preparation of morphinans
05/28/1998WO1998022465A1 A1 adenosine receptor antagonists
05/28/1998WO1998022464A1 Xanthines and their therapeutic use
05/28/1998WO1998022461A1 Epothilone c, d, e and f, production process, and their use as cytostatic as well as phytosanitary agents
05/28/1998WO1998022460A1 Bicyclic aryl carboxamides and their therapeutic use
05/28/1998WO1998022459A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
05/28/1998WO1998022458A1 Multivalent salts of pyridostigmine and related compounds
05/28/1998WO1998022457A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
05/28/1998WO1998022453A1 Substituted dihydrobenzofurans as pde inhibitors
05/28/1998WO1998022443A1 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
05/28/1998WO1998022441A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
05/28/1998WO1998022436A1 Substituted 4-biphenyl-4-hydroxybutyric acid derivatives as matrix metalloprotease inhibitors
05/28/1998WO1998022433A1 N-(ARYL/HETEROARYL/ALKYLACETYL) AMINO ACID AMIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022430A1 N-(ARYL/HETEROARYLACETYL) AMINO ACID ESTERS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING b-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
05/28/1998WO1998022426A1 New manufacturing process of metoprolol
05/28/1998WO1998022423A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/28/1998WO1998022418A1 Substituted phenols and thiophenols useful as antioxidant agents
05/28/1998WO1998022136A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
05/28/1998WO1998022133A1 NOVEL FabD
05/28/1998WO1998022132A1 A method and composition for enabling passage through the blood-brain barrier
05/28/1998WO1998022113A1 Methods of prevention and treatment of ischemic damage
05/28/1998WO1998022112A1 Drug resistance and multidrug resistance modulators
05/28/1998WO1998022111A1 Anti-helicobacter pylori drugs
05/28/1998WO1998022109A1 Triaryl substituted imidazoles as glucagon antagonists
05/28/1998WO1998022108A1 Triaryl substituted imidazoles and methods of use
05/28/1998WO1998022107A1 Stabilised pharmaceutical compositions, with quinupristine and dalfopristine base and their preparation
05/28/1998WO1998022106A1 Pharmaceutical composition
05/28/1998WO1998022105A1 Tabletted preparation
05/28/1998WO1998022104A2 Treatment of neurodegenerative conditions with nimesulide
05/28/1998WO1998022103A1 Raf kinase inhibitors
05/28/1998WO1998022102A1 Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity
05/28/1998WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
05/28/1998WO1998022100A2 New use for 1,3-propanediol derivatives
05/28/1998WO1998022099A2 New use of creatine
05/28/1998WO1998022098A2 Cpp32 inhibitors for regulating apoptosis
05/28/1998WO1998022091A1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF β-LACTAM ANTIBIOTICS
05/28/1998WO1998022090A1 Treatment of equine laminitis
05/28/1998WO1998022087A1 Detergent cosmetic compositions and use thereof
05/28/1998WO1998022083A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof
05/28/1998WO1998022081A1 Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne
05/28/1998WO1998021958A1 Nefazodone: use in treating post traumatic stress disorder
05/28/1998WO1998021957A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
05/28/1998WO1998021956A1 Heregulin antagonists and methods for their use
05/28/1998WO1998021949A1 Medical use of composition comprising fatty acids
05/28/1998WO1998021947A1 Compositions and treatment for nighttime persistent reproductive transition symptoms
05/28/1998WO1998021946A1 Composition and treatment for persistent reproductive transition symptoms
05/28/1998WO1998016503A3 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/28/1998WO1998016184A3 Purine l-nucleosides, analogs and uses thereof
05/28/1998WO1998002191A3 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
05/28/1998DE19649460A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives
05/28/1998DE19648793A1 Neue Benzamide und deren Anwendung New benzamides and their application
05/28/1998DE19647100A1 Urea skin moisturising salve with good stability
05/28/1998DE19646971A1 Zusammensetzung zur Verringerung des Blutzuckerspiegels Composition for reducing the blood sugar level
05/28/1998CA2505430A1 Pharmaceutical compositions of hiv protease inhibitors with improved oral bioavailability
05/28/1998CA2275438A1 Improved methods for transducing cells
05/28/1998CA2273183A1 Treatment of equine laminitis
05/28/1998CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon
05/28/1998CA2272433A1 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis
05/28/1998CA2272390A1 Drug resistance and multidrug resistance modulators
05/28/1998CA2272385A1 Nefazodone: use in treating post traumatic stress disorder
1 ... 6648 6649 6650 6651 6652 6653 6654 6655 6656 6657 6658 6659 6660 6661 6662 6663 6664 6665 6666 6667 6668 ... 7860